Table: Ono Pharm -Q1 group results (IFRS)

ONO PHARMACEUTICAL

01/08/2022 04:00

Aug 1 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2022        Jun 30, 2021     Mar 31, 2023 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              106.72               87.36           425.00    
                   (+22.2 pct)         (+16.6 pct)      (+17.6 pct) 
  Operating           38.16               29.79           145.00    
                   (+28.1 pct)         (+10.2 pct)      (+40.5 pct) 
  Pretax              39.04               30.80           146.00    
                   (+26.7 pct)         (+8.8 pct)       (+39.0 pct) 
  Net                 29.48               24.07           110.00    
                   (+22.4 pct)         (+12.0 pct)      (+36.6 pct) 
  EPS Basic         60.37 yen           48.23 yen       225.30 yen  
  EPS Diluted       60.36 yen           48.22 yen                   
  Ann Div                               56.00 yen        66.00 yen  
  -Q2 Div                               28.00 yen        33.00 yen  
  -Q4 Div                               28.00 yen        33.00 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T